Clinical trial
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
NCT00096616
Study timeline
Study start (unknown)2004-11-01Date precision: month
Registry last updated2013-11-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
Sponsors & collaborators
Boehringer Ingelheimlead sponsor
Mapped research locations
BirminghamAlabama, United States2New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1BaltimoreMaryland, United States1MiamiFlorida, United States1DurhamNorth Carolina, United States1CharlestonSouth Carolina, United States1Winston-SalemNorth Carolina, United States1MadisonWisconsin, United States1SpartanburgSouth Carolina, United States1ShreveportLouisiana, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00096616 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.